A small subpopulation of blastospores in Candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and β-1,6-glucan pathway genes

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 11, 2006, Pages 3708-3716

  Knot, Prasanna D ^a,d   Suci, Peter A ^b   Miller, R Lance ^c   Nelson, Raoul D ^c   Tyler, Bonnie J ^a  

^a Department of Electrical and Computer Engineering   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BETA 1,6 GLUCAN; ERGOSTEROL; ERGOSTEROL 1; ERGOSTEROL 11; ERGOSTEROL 25; ERGOSTEROL 3; ERGOSTEROL 5; ERGOSTEROL 6; ERGOSTEROL 9; GENE PRODUCT; PROTEIN KRE 1; PROTEIN KRE 5; PROTEIN KRE 6; PROTEIN KRE 9; PROTEIN SKN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL MEMBRANE; CELL SUBPOPULATION; CELL WALL; CYTOARCHITECTURE; FORCE; GENE EXPRESSION REGULATION; GENETIC CODE; GENETIC TRANSCRIPTION; MORPHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANKTON; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBE FLOW;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; BETA-GLUCANS; BIOFILMS; CANDIDA ALBICANS; DNA PRIMERS; DNA, COMPLEMENTARY; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; ERGOSTEROL; GENES, FUNGAL; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, FUNGAL; SPORES, FUNGAL; TRANSCRIPTION, GENETIC;

EID: 33750590848     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00997-06     Document Type: Article

References (77)

1. Akins, R. A. 2005. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med. Mycol. 43:285-318.
2. Anderl, J. N., J. Zahller, F. Roe, and P. S. Stewart. 2003. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 47:1251-1256.
3. Andes, D., J. Nett, P. Oschel, R. Albrecht, K. Marchillo, and A. Pitula. 2004. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect. Immun. 72:6023-6031.
4. Anwar, H., M. Dasgupta, K. Lam, and J. W. Costerton. 1989. Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation. J. Antimicrob. Chemotherapy 24:647-655.
5. Arnaud, M. B., M. C. Costanzo, M. S. Skrzypek, G. Binkley, C. Lane, S. R. Miyasato, and G. Sherlock. 2005. The Candida Genome Database (CGD), a community resource for Candida albicans gene and protein information. Nucleic Acids Res. 33:D358-D363.
6. Bachmann, S. P., K. VandeWalle, G. Ramage, T. F. Patterson, B. L. Wickes, J. R. Graybill, and J. L. Lopez-Ribot. 2002. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46:3591-3596.
7. Baillie, G. S., and L. J. Douglas. 1998. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob. Agents Chemother. 42:1900-1905.
8. Baillie, G. S., and L. J. Douglas. 2000. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemotherapy 46:397-403.
9. Baillie, G. S., and L. J. Douglas. 1999. Role of dimorphism in the development of Candida albicans biofilms. J. Med. Microbiol. 48:671-679.
10. Barker, K. S., S. Crisp, N. Wiederhold, R. E. Lewis, B. Bareither, J. Eckstein, R. Barbuch, M. Bard, and P. D. Rogers. 2004. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J. Antimicrob. Chemother. 54:376-385.
11. Beggs, K. T., A. R. Holmes, R. D. Cannon, and A. M. Rich. 2004. Detection of Candida albicans mRNA in archival histopathology samples by reverse transcription-PCR. J. Clin. Microbiol. 42:2275-2278.
12. Boone, C., A. M. Sdicu, M. Laroche, and H. Bussey. 1991. Isolation from Candida albicans of a functional homolog of the Saccharomyces cerevisiae kre1 gene, which is involved in cell wall beta-glucan synthesis. J. Bacteriol. 173:6859-6864.
13. Boone, C., S. S. Sommer, A. Hensel, and H. Bussey. 1990. Yeast Kre genes provide evidence for a pathway of cell-wall beta-glucan assembly. J. Cell Biol. 110:1833-1843.
14. Breinig, F., K. Schleinkofer, and M. J. Schmitt. 2004. Yeast Kre1p is GPI-anchored and involved in both cell wall assembly and architecture. Microbiology SGM 150:3209-3218.
15. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183:5385-5394.
16. Chandra, J., P. K. Mukherjee, S. D. Leidich, F. F. Faddoul, L. L. Hoyer, L. J. Douglas, and M. A. Ghannoum. 2001. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J. Dent. Res. 80:903-908.
17. Cochran, W. L., G. A. McFeters, and P. S. Stewart. 2000. Reduced susceptibility of thin Pseudomonas aeruginosa biofilms to hydrogen peroxide and monochloramine. J. Appl. Microbiol. 88:22-30.
18. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
19. Crump, J. A., and P. J. Collignon. 2000. Intravascular catheter-associated infections. Eur. J. Clin. Microbiol. Infect. Dis. 19:1-8.
20. Das, J. R., M. Bhakoo, M. V. Jones, and P. Gilbert. 1998. Changes in the biocide susceptibility of Staphylococcus epidermadis and Escherichia coli cells associated with rapid attachment to plastic surfaces. J. Appl. Microbiol. 84:852-858.
21. Daum, G., N. D. Lees, M. Bard, and R. Dickson. 1998. Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae. Yeast 14:1471-1510.
22. Davies, D. 2003. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discovery 2:114-122.
23. Davies, D. G., and G. G. Geesey. 1995. Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl. Environ. Microbiol. 61:860-867.
24. Debeer, D., P. Stoodley, F. Roe, and Z. Lewandowski. 1994. Effects of biofilm structures on oxygen distribution and mass transport. Biotechnol. Bioeng. 43:1131-1138.
25. Douglas, L. J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.
26. Gale, E. F. 1986. Nature and development of phenotypic resistance to amphotericin B in Candida albicans. Adv. Microb. Physiol. 27:277-320.
27. Gale, E. F. 1974. The release of potassium ions from Candida albicans in the presence of polyene antibiotics. J. Gen. Microbiol. 80:451-465.
28. Gale, E. F., E. A. Miles, D. Kerridge, and A. M. Johnson. 1978. Phenotypic resistance to amphotericin B in Candida albicans: role of reduction. J. Gen. Microbiol. 109:191-204.
29. Ghannoum, M. A., and L. B. Rice. 1999. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12:501-517.
30. Gilbert, P., P. J. Collier, and M. R. W. Brown. 1990. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob. Agents Chemother. 34:1865-1868.
31. Givskov, M., L. Eberl, and S. Molin. 1994. Responses to nutrient starvation in Pseudomonas putida Kt2442: two-dimensional electrophoretic analysis of starvation-induced and stress-induced proteins. J. Bacteriol. 176:4816-4824.
32. Gomez-Suarez, C., H. J. Busscher, and H. C. van der Mei. 2001. Analysis of bacterial detachment from substratum surfaces by the passage of air-liquid interfaces. Appl. Environ Microbiol. 67:2531-2537.
33. Green, C. B., G. Cheng, J. Chandra, P. Mukherjee, M. A. Ghannoum, and L. L. Hoyer. 2004. RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology SGM 150:267-275.
34. Gudlaugsson, O., S. Gillespie, K. Lee, J. V. Berg, J. F. Hu, S. Messer, L. Henvaldt, M. Pfaller, and D. Diekema. 2003. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 37:1172-1177.
35. Han, Y. M., R. P. Morrison, and J. E. Cutler. 1998. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect. Immun. 66:5771-5776.
36. Hawser, S. P., and L. J. Douglas. 1995. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 39:2128-2131.
37. Huang, C. T., K. D. Xu, G. A. McFeters, and P. S. Stewart. 1998. Spatial patterns of alkaline phosphatase expression within bacterial colonies and biofilms in response to phosphate starvation. Appl. Environ Microbiol. 64:1526-1531.
38. Kerridge, D., T. Y. Koh, and A. M. Johnson. 1976. The interaction of amphotericin B methyl ester with protoplasts of Candida albicans. J. Gen. Microbiol. 96:117-123.
39. Kilic, A. O., L. Tao, Y. S. Zhang, Y. Lei, A. Khammanivong, and M. C. Herzberg. 2004. Involvement of Streptococcus gordonii beta-glucoside metabolism systems in adhesion, biofilm formation, and in vivo gene expression. J. Bacteriol. 186:4246-4253.
40. Klis, F. M., P. De Groot, and K. Hellingwerf. 2001. Molecular organization of the cell wall of Candida albicans. Med. Mycol. 39:1-8.
41. Kojic, E. M., and R. O. Darouiche. 2004. Candida infections of medical devices. Clin. Microbiol. Rev. 17:255-267.
42. Kuhn, D. M., J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. A comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70:878-888.
43. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
44. Lamfon, H., S. R. Porter, M. McCullough, and J. Pratten. 2004. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study. J. Antimicrob. Chemother. 53:383-385.
45. Lewis, K. 2001. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45:999-1007.
46. Lewis, R. E., D. P. Kontoyiannis, R. O. Darouiche, Raad, I. I., and R. A. Prince. 2002. Antifungal activity of amphotericin B, fluconazole and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob. Agents Chemother. 46:3499-3505.
47. McBride, J., P. R. Ingram, F. L. Henriquez, and C. W. Roberts. 2005. Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba. J. Clin. Microbiol. 43:629-634.
48. McDonnell, G., and A. D. Russell. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev. 12:147-179. (Erratum, 14:227-228, 2001.)
49. Mio, T., T. Yamada-Okabe, T. Yabe, T. Nakajima, M. Arisawa, and H. Yamada-Okabe. 1997. Isolation of the Candida albicans homologs of Saccharomyces cerevisiae KRE6 and SKN1: expression and physiological function. J. Bacteriol. 179:2363-2372.
50. Moorthy, S., and P. I. Watnick. 2004. Genetic evidence that the Vibrio cholerae monolayer is a distinct stage in biofilm development. Mol. Microbiol. 52:573-587.
51. Muller, P. Y., H. Janovjak, A. R. Miserez, and Z. Dobbie. 2002. Processing of gene expression data generated by quantitative real-time RT-PCR. BioTechniques 32:1372-1379.
52. NCCLS. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. NCCLS document M27-A. NCCLS, Wayne, Pa.
53. Nichols, W. W., S. M. Dorrington, M. P. E. Slack, and H. L. Walmsley. 1988. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob. Agents Chemother. 32:518-523.
54. Nichols, W. W., M. J. Evans, M. P. E. Slack, and H. L. Walmsley. 1989. The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J. Gen. Microbiol. 135:1291-1303.
55. Odds, F. C. 1988. Candida and candidosis. Baillière Tindall, London, England.
56. Pasrija, R., S. Krishnamurthy, T. Prasad, J. F. Ernst, and R. Prasad. 2005. Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans. J. Antimicrob. Chemother. 55:905-913.
57. Pfaller, M. A., and A. L. Barry. 1994. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32:1992-1996.
58. Pfaller, M. A., and D. J. Diekema. 2002. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J. Clin. Microbiol. 40:3551-3557.
59. Prigent-Combaret, C., O. Vidal, C. Dorel, and P. Lejenne. 1999. Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. J. Bacteriol. 181:5993-6002.
60. Ramage, G., S. P. Seville, D. P. Thomas, and J. L. Lopez-Ribot. 2005. Candida biofilms: an update. Eukaryot. Cell 4:633-638.
61. Ramage, G., K. vande Walle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
62. Ramage, G., K. VandeWalle, S. P. Bachmann, B. L. Wickes, and J. L. Lopez-Ribot. 2002. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob. Agents Chemother. 46:3634-3636.
63. Ramage, G., K. Vandewalle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol. 18:163-170.
64. Rex, J. H., M. A. Pfaller, T. J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, M. A. Ghannoum, L. L. Gosey, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, and D. W. Warnock. 2001. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 14:643-658.
65. Rozen, S., and H. Skaletsky. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132:365-386.
66. Ruiz-Herrera, J., M. V. Elorza, E. Valentin, and R. Sentandreu. 2006. Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity. FEMS Yeast Res. 6:14-29.
67. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
68. Stewart, P. S., and J. W. Costerton. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
69. Snci, P. A., G. G. Geesey, and B. J. Tyler. 2001. Integration of Raman microscopy, differential interference contrast microscopy, and attenuated total reflection Fourier transform infrared spectroscopy to investigate chlorhexidine spatial and temporal distribution in Candida albicans biofilms. J. Microbiol. Methods 46:193-208.
70. Suci, P. A., and B. J. Tyler. 2002. Action of chlorhexidine digluconate against yeast and filamentous forms in an early-stage Candida albicans biofilm. Antimicrob. Agents Chemother. 46:3522-3531.
71. Suci, P. A., and B. J. Tyler. 2003. A method for discrimination of subpopulations of Candida albicans biofilm cells that exhibit relative levels of phenotypic resistance to chlorhexidine. J. Microbiol. Methods 53:313-325.
72. Tiballi, R. N., X. He, L. T. Zarins, S. G. Revankar, and C. A. Kauffman. 1995. Use of a colorimetric system for yeast susceptibility testing. J. Clin. Microbiol. 33:915-917.
73. Vandesompele, J., K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034.
74. Watts, H. J., A. A. Very, T. H. S. Perera, J. M. Davies, and N. A. R. Gow. 1998. Thigmotropism and stretch-activated channels in the pathogenic fungus Candida albicans. Microbiology UK 144:689-695.
75. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
76. Wilson, S., M. A. Hamilton, G. C. Hamilton, M. R. Schumann, and P. Stoodley. 2004. Statistical quantification of detachment rates and size distributions of cell clumps from wild-type (PAO1) and cell signaling mutant (JP1) Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 70:5847-5852.
77. Xu, K. D., P. S. Stewart, F. Xia, C. T. Huang, and G. A. McFeters. 1998. Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl. Environ. Microbiol. 64:4035-4039.